The popularity of copyright’s blockbuster initially drove a period of growth for pharma, nevertheless recent shifts present a uncertain scenario for shareholders. Off-patent competitors are eroding profits, and https://joyceoasf697289.suomiblog.com/sildenafil-and-big-pharma-a-risky-bet-57003836